Eisai
Andrew Pachuta is an experienced professional in project management and global commercial strategy, currently serving as Associate Director of Project Management for Alzheimer's Disease at Eisai US since August 2025. Prior roles include Principal Project Manager at Sanofi, where Andrew led launch readiness plans and trained personnel, and Manager of Global Commercial Strategy and Operations at The Janssen Pharmaceutical Companies, focusing on strategic initiatives and innovation. Earlier career experiences include consulting at Herspiegel Consulting, where Andrew oversaw product launches, and a market access internship at Novo Nordisk that earned recognition in a case study competition. Andrew holds an M.B.A. in Strategic Management/Marketing from Villanova University and a B.S. in Economics/Finance from Rider University.
This person is not in any teams
This person is not in any offices
Eisai
12 followers
Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical segment and other segment. The pharmaceutical segment is engaged in the research, develop, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The other segment consists of pharmaceutical raw materials, logistics services and business services businesses.